Amplia Therapeutics Ltd. (AU:ATX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Amplia Therapeutics Ltd. has announced an upcoming webinar featuring CEO Dr. Chris Burns, who will introduce the company and its focus on developing FAK inhibitors for treating cancer and fibrosis. The presentation will include a live Q&A session and is part of a series by Sharewise, accessible online to shareholders and interested parties. Amplia is targeting diseases like pancreatic cancer and idiopathic pulmonary fibrosis with their research into FAK, a promising area in cancer treatment.
For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.